SEC Form 5 · accession 0001570523-18-000004
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 28, 2018 · 6:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Feb 24, 2017 | P | 200 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 20, 2017 | P | 300 | $0.03 | A | 22,059,859 | D | |
| Common stock | Mar 20, 2017 | P | 200 | $0.03 | A | 22,059,859 | D | |
| Common stock | Mar 22, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 22, 2017 | P | 100 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 23, 2017 | P | 15,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 29, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 29, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 29, 2017 | P | 2,820 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 29, 2017 | P | 10,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 29, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 30, 2017 | P | 7,180 | $0.05 | A | 22,059,859 | D | |
| Common stock | Mar 31, 2017 | P | 5,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 31, 2017 | P | 15,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 31, 2017 | P | 1,250 | $0.04 | A | 22,059,859 | D | |
| Common stock | Mar 31, 2017 | P | 3,750 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 3, 2017 | P | 1,250 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 3, 2017 | P | 750 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 3, 2017 | P | 2,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 5, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 1,250 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 3,750 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 3,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 2,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 12, 2017 | P | 1,000 | $0.04 | A | 22,059,859 | D | |
| Common stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D | |
| Common stock | Apr 13, 2017 | P | 1,000 | $0.05 | A | 22,059,859 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 2 of 16 submissions.